drugset / Trial / NCT06056687
Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to investigate the effect of alpha-lipoic acid on inflammatory markers and cardiac fibrosis markers in diabetic patients with Ischemic Cardiomyopathy.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2024-01-31
- Completion
- 2024-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | alpha-lipoic acid | Small molecule | 600 mg | Oral |